New chemo combo tested for rare, aggressive gut cancer
NCT ID NCT04325425
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 25 times
Summary
This study tests whether a chemotherapy regimen called FOLFIRINOX works better than the standard platinum-etoposide combination for people with a rare, fast-growing neuroendocrine cancer that has spread. About 218 adults with this cancer will be randomly assigned to one of the two treatments. The study also looks at tumor genetics to find markers that could predict which treatment works best for each person.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CH de Troyes
RECRUITINGTroyes, 10003, France
Contact Email: •••••@•••••
-
Centre Hospitalier de Saint Malo
RECRUITINGSt-Malo, 35403, France
Contact Email: •••••@•••••
-
Chu Dijon Bourgogne
RECRUITINGDijon, 21000, France
Contact Email: •••••@•••••
-
Chu de Caen
RECRUITINGCaen, 14033, France
Contact Email: •••••@•••••
-
Chu de Limoges - Dupuytren
RECRUITINGLimoges, 87042, France
Contact Email: •••••@•••••
-
Institut de Cancérologie de Bourgogne
RECRUITINGDijon, 21000, France
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.